Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease

Di Paolo N, Bocci V, Salvo DP, et al. International Journal of Artificial Organs, 2005.

View the abstract on PubMed

Study type
Randomized controlled trial
People studied
28 people
Population
Patients with peripheral artery disease
Published
2005, International Journal of Artificial Organs
Identifiers
PMID 16288443, DOI 10.1177/039139880502801012
Group
Studies of EBO2 / EBOO specifically

What the authors reported

In 28 patients randomized to EBOO or intravenous prostacyclin, EBOO produced significantly greater regression of ischemic skin lesions and improved pain and well-being, with no significant difference in measured arterial circulation between groups.

What limits this result

Small sample of 28 patients from a single Italian center; the available abstract does not describe blinding of outcome assessment or the randomization method.

Research on the procedure itself. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.

Where we cite this study

All studies we track